Background: Clinical evidence suggests that body muscle mass is positively associated with bone mass, of significance for the elderly population at risk of osteoporosis (OP). Furthermore, muscle and bone interact mechanically and functionally, via local interactions as well as remotely via secreted components. Thus, it was of interest to compare muscle transcriptomes in postmenopausal OP and healthy women, and study effects of strength training on the muscle transcriptome, muscle stress proteins and bone mineral density (BMD). Methods: Skeletal muscle histological and genetic properties were compared in postmenopausal healthy ( n = 18) and OP ( n = 17) women before and after heavy-load strength training for 13–15 weeks. The cohorts were o...
The interaction between muscle and bone is complex. The aim of this study was to investigate if vari...
Female middle age is characterized by a decline in skeletal muscle mass and performance, predisposi...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...
Clinical evidence suggests that body muscle mass is positively associated with bone mass, of signifi...
At the moment, there is no clear molecular explanation for the steeper decline in muscle performance...
The aim of this research was to investigate myogenic (i.e. growth) and proteolytic (i.e. breakdown) ...
The loss of muscle mass and strength with aging is well characterized, but our knowledge of the mole...
Background. Skeletal muscle atrophy in rodents is associated with increased gene expression of prote...
mass and strength in the lower body will be expected to reduce the risk of falling because low muscl...
Assessment of the association of muscle strength and muscle mass with osteoporosis (OP) is of specia...
Rationale: Osteoporosis is a global problem that affects one in three women and one in 12 men. More ...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...
This cross-sectional study investigated the association between osteoporosis, grip strength, and ske...
Introduction: Osteoporosis is a systemic disease of the bone, which entails an increased riskof frac...
The interaction between muscle and bone is complex. The aim of this study was to investigate if vari...
Female middle age is characterized by a decline in skeletal muscle mass and performance, predisposi...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...
Clinical evidence suggests that body muscle mass is positively associated with bone mass, of signifi...
At the moment, there is no clear molecular explanation for the steeper decline in muscle performance...
The aim of this research was to investigate myogenic (i.e. growth) and proteolytic (i.e. breakdown) ...
The loss of muscle mass and strength with aging is well characterized, but our knowledge of the mole...
Background. Skeletal muscle atrophy in rodents is associated with increased gene expression of prote...
mass and strength in the lower body will be expected to reduce the risk of falling because low muscl...
Assessment of the association of muscle strength and muscle mass with osteoporosis (OP) is of specia...
Rationale: Osteoporosis is a global problem that affects one in three women and one in 12 men. More ...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...
This cross-sectional study investigated the association between osteoporosis, grip strength, and ske...
Introduction: Osteoporosis is a systemic disease of the bone, which entails an increased riskof frac...
The interaction between muscle and bone is complex. The aim of this study was to investigate if vari...
Female middle age is characterized by a decline in skeletal muscle mass and performance, predisposi...
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne...